Wolf Theiss Advises CapVest on Acquisition of Majority Stake in STADA

"Wolf Theiss, together with Willkie Farr & Gallagher, advised CapVest Partners on its acquisition of a majority stake in German pharmaceuticals group STADA from Bain Capital and Cinven. Kirkland & Ellis reportedly advised the sellers. STADA’s Serbian subsidiaries include Hemofarm."

Wolf Theiss, working with Willkie Farr & Gallagher, advised CapVest Partners on the transaction, while Kirkland & Ellis reportedly advised sellers Bain Capital and Cinven. The transaction involves CapVest Partners' acquisition of a majority stake in STADA from Bain Capital and Cinven. STADA is a Germany‑headquartered pharmaceuticals company; its Serbian subsidiaries include Hemofarm. Wolf Theiss represented client(s) CapVest Partners with a team composed by: Partners Andjelka Todorovic and Aleksandar Ristic, Counsel Katarina Stojakovic, Senior Associates Jovan Micovic and Katarina Randjelovic, and Associates Vjera Vlahovic and Stefan Silobad. Willkie Farr & Gallagher represented client(s) CapVest Partners. Kirkland & Ellis reportedly represented client(s) Bain Capital and Cinven.

Menu

Wolf Theiss Advises CapVest on Acquisition of Majority Stake in STADA

Read the full story

Menu

Wolf Theiss Advises CapVest on Acquisition of Majority Stake in STADA

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads